Daiichi Sankyo Email Format

Pharmaceutical Manufacturing
10,001+ employees
Tokyo, Japan

Daiichi Sankyo is a global pharmaceutical company headquartered in Tokyo that discovers, develops, and delivers innovative medicines for oncology, cardiovascular, and other diseases with high unmet medical needs.

Find contacts at Daiichi Sankyo

Search our verified sources for decision-makers, emails, and titles.

Start searching
VERIFIED BY CLAY

first.last@daiichisankyo.com

Company Overview

Industry
Pharmaceutical Manufacturing
Founded
1899
Headquarters
Tokyo, Japan
Revenue
$10B-$25B
FUNDING Stage
Public
Key Executives
Hiroyuki Okuzawa (Representative Director, President and Chief Executive Officer), Tomohiro Kodama (Senior Executive Officer, Head of Global Corporate Planning & Management)

Tech Stack

Azure OpenAI Service

Cloud

Signup

to know

Signup

to know

Signup

to know

Key Executives

Chief Executive Officer

Find the current person →

Chief Finance Officer

Find the current person →

Chief Operating Officer

Find the current person →

Chief Technology Officer

Find the current person →

Chief Marketing Officer

Find the current person →

Chairman

Find the current person →

4.9/5 on G2
40K+ GTM professionals
SOC 2 Type II certified

Frequently Asked Questions

What is the email format of Daiichi Sankyo?

Daiichi Sankyo uses the first.last format, so Jane Smith would be jane.smith@daiichisankyo.com.

What is Daiichi Sankyo's proprietary DXd ADC technology platform?

Daiichi Sankyo's DXd ADC platform is the company's original antibody-drug conjugate technology, combining a monoclonal antibody with a topoisomerase I inhibitor payload. In 2026, the platform underpins seven core clinical assets targeting cancer types including breast, lung, gastric, and ovarian cancers.

How does Daiichi Sankyo collaborate with AstraZeneca on ENHERTU?

Daiichi Sankyo and AstraZeneca entered a global collaboration in 2019 to jointly develop and commercialize ENHERTU (trastuzumab deruxtecan), a HER2-directed antibody-drug conjugate. The two companies share development responsibilities worldwide, with Daiichi Sankyo retaining exclusive rights in Japan.

Who leads Daiichi Sankyo as CEO in 2026?

Hiroyuki Okuzawa serves as Representative Director, President and Chief Executive Officer of Daiichi Sankyo, having assumed the role on April 1, 2025. You can use Clay to find and verify his current contact details or other Daiichi Sankyo leadership for outreach purposes.

Where is Daiichi Sankyo headquartered and what is its global presence like?

Daiichi Sankyo is headquartered in Tokyo, Japan and operates globally with a workforce of over 10,000 employees, running research, development, and commercial operations across multiple regions including the US, Europe, and Asia.

Share Article

Get access to more people and company data using Clay

Leverage the power of 100+ data providers for industry-leading data coverage & quality.

4.9 rating

More Articles